Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Dopamine receptor inhibitor
BML-D103-0010 10 mg 262.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-550-204

Potent dopamine re-uptake inhibitor.

Product Details

Formula:C19H25NS . C4H4O4
Purity:≥98% (HPLC)
Identity:Determined by MS.
Appearance:Off-white solid.
Solubility:Soluble in 100% ethanol.
Shipping:Ambient Temperature
Long Term Storage:+4°C
Use/Stability:Store, as supplied, at 0-4°C for up to 1 year. Store solutions at -20°C for up to 3 months.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

Further studies of the structure-activity relationships of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine. Synthesis and evaluation of 1-(2-benzo[b]thienyl)-N,N-dialkylcyclohexylamines at dopamine uptake and phencyclidine binding sites: X. He, et al.; J. Med. Chem. 36, 4075 (1993), Abstract;
Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites: X. He, et al.; J. Med. Chem. 26, 1188 (1993), Abstract;
Differential interaction of phencyclidine-like drugs with the dopamine uptake complex in vivo: T. Maurice et al.; J. Neurochem. 56, 553 (1991), Abstract;
The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801: W. Koek et al.; J. Pharmacol. Exp. Ther. 250, 1019 (1989), Abstract;
[3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP): a new phencyclidine analog selective for the dopamine uptake complex: J. Vignon et al.; Eur. J. Pharmacol. 148, 427 (1988), Abstract;

Related Literature

Download as PDF

All new literature pieces